Clinical Research

Clinical research is a vital component of today's ever-evolving healthcare field, allowing physicians and providers to break new ground and giving patients new alternatives to lifesaving treatment options. UnityPoint Health - Meriter regularly participates in clinical research — giving us the opportunity to test the safety and effectiveness of new treatments such as medicines, medical procedures and devices.

Patients volunteer to participate in clinical research because they hope it will benefit them and because they want to contribute to a research effort that helps patients in the future. Whether the outcome of clinical research is beneficial or disappointing, patients involved in clinical research are helping to find new and better treatments.

If you are interested in learning more about a specific research project, please contact the person listed.

Heart & Vascular

  • AMGEN 18 - A Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Statin Therapy in Subjects With Primary Hypercholesterole
  • ARRY 797 231-Pilot Study to Investigate the Efficacy and Safety of ARRAY-371797 in Patients with Symptomatic Familial Dilated Cardiomyopathy Due to Lamin A/C Gene Mutation
  • BEST-CLI - Randomized, Multicenter, Controlled Trial to Compare Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia
  • CANTOS - A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial patients
  • DECLARE TIMI 58 - Dapagliflozin Effect on Cardiovascular Events
  • EUCLID - Examining Use of TiCagreLor In peripheral artery Disease
  • LSS 4-Site - The Longitudinal Surveillance Study of the 4-SITE
  • PROMUS - Element Plus US Post-Approval Study
  • REVEAL - Randomized Evaluation of the Effects of Anacetrapib through Lipid Modification
  • SAFE-DBC - A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix® 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA)
  • VOYAGER - Vascular Outcomes study of Asa along with rivaroxaban in Endovascular or surgical limb Revascularization for peripheral artery disease (PAD)

Women's Health, including Maternal, Prenatal Health and Newborns

  • 2010-001 - Determining PCOS-like traits in macaques and newborn
  • 2013-013 - Early diagnosis of urinary tract infection, necrotizing
  • 2013-009 - Randomized Control Trial of Hydralazine, Labetalol and Nifedipine in Treatment of Severe Hypertension in Pregnancy
  • 2013-015 - Use of amplitude-integrated electroencephalography
  • 2015-012 - ROPE - Shire - Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity - A Phase 2, Randomized Controlled, Assessor-blind, Doesconfirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study.